Allen S. Melemed's most recent trade in Chimerix Inc was a trade of 400,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Chimerix Inc | Allen S. Melemed | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 400,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Allen S. Melemed | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 275,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Allen S. Melemed | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 240,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Allen S. Melemed | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 190,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Allen S. Melemed | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 8.55 per share. | 21 Apr 2025 | 173,852 | 0 (0%) | 0% | 8.6 | 1,486,435 | Common Stock |
| Chimerix Inc | Allen S. Melemed | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 168,750 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Allen S. Melemed | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 154,260 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Allen S. Melemed | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.50 per share. | 13 Feb 2025 | 3,065 | 152,875 (0%) | 0% | 4.5 | 13,799 | Common Stock |
| Chimerix Inc | Allen S. Melemed | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Chimerix Inc | Allen S. Melemed | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 45,925 | 155,940 (0%) | 0% | 0 | Common Stock | |
| Chimerix Inc | Melemed S. Allen | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 168,750 | 168,750 | - | - | Stock Option (Right to Buy) | |
| Chimerix Inc | Allen Melemed S. | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 28,125 | 86,430 (0%) | 0% | 0 | Common Stock | |
| Chimerix Inc | Allen S. Melemed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 154,260 | 154,260 | - | - | Stock Option (Right to Buy) | |
| Chimerix Inc | Allen S. Melemed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 25,740 | 47,887 (0%) | 0% | 0 | Common Stock | |
| Chimerix Inc | Allen S. Melemed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | |
| Chimerix Inc | Allen S. Melemed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) |